BONE MINERAL DENSITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A CLINICAL EVALUATION
Scientific and Innovative Therapy · 2025
DOI: 10.64582/ivit.uz.140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific and Innovative Therapy, 2025. Verfasst von Shoxida Naimova. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
The clinical significance of osteoporosis in rheumatic diseases, especially in patients with rheumatoid arthritis, is that it causes irreversible changes in the osteoarticular system, exudative-proliferative inflammation, ankylosis and pathological fractures, adversely affecting the quality of life of patients and the outcome of the disease. In the department of "Rheumatology" of the Bukhara Regional Multidisciplinary Medical Center, 60 patients with rheumatoid arthritis, who were hospitalized for 6 months, were examined. In patients with RA in the postmenopausal phase, high disease activity was found to have a strong direct correlation with osteopenia and osteoporosis resulting from changes in BMD (bone mineral density).
Zitieren
APA
Naimova, S. (2025). BONE MINERAL DENSITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A CLINICAL EVALUATION. Scientific and Innovative Therapy. https://doi.org/10.64582/ivit.uz.140
Vancouver
Naimova S. BONE MINERAL DENSITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A CLINICAL EVALUATION. Scientific and Innovative Therapy. 2025. doi:10.64582/ivit.uz.140
BibTeX
@article{Naimova2025,
author = {Naimova, Shoxida},
title = {BONE MINERAL DENSITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A CLINICAL EVALUATION},
journal = {Scientific and Innovative Therapy},
year = {2025},
doi = {10.64582/ivit.uz.140}
}
EUVIMED